Hypercholesterolaemia impairs monocyte function in CAD patients

Journal of Internal Medicine

Volumn 261, Issue 2, 2007, Pages 201-204

  Czepluch, F S ^a,b   Bergler, A ^b   Waltenberger, J ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarker; Coronary artery disease; Hypercholesterolaemia; Monocyte chemoattractant protein 1; Monocytes; Vascular endothelial growth factor

Indexed keywords

LIGAND; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CELL FUNCTION; CELL MIGRATION; CHEMOTAXIS; CLINICAL ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; ANTICHOLESTEREMIC AGENTS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOTAXIS; CHOLESTEROL, LDL; COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MONOCYTES; SIMVASTATIN; STATISTICS, NONPARAMETRIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846143528     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2006.01753.x     Document Type: Article

References (8)

1. Van Weel V, de Vries M, Voshol PJ et al. Hypercholesterolemia reduces collateral artery growth more dominantly than hyperglycemia or insulin resistance in mice. Arterioscler Thromb Vasc Biol 2006; 26: 1383-90.
2. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1998; 101: 40-50.
3. Khmelewski E, Becker A, Meinertz T, Ito WD. Tissue resident cells play a dominant role in arteriogenesis and concomitant macrophage accumulation. Circ Res 2004; 95: E56-64.
4. Tirziu D, Moodie KL, Zhuang ZW et al. Delayed arteriogenesis in hypercholesterolemic mice. Circulation 2005; 112: 2501-9.
5. Babiak A, Schumm AM, Wangler C et al. Coordinated activation of VEGFR-1 and VEGFR-2 is a potent arteriogenic stimulus leading to enhancement of regional perfusion. Cardiovasc Res 2004; 61: 789-95.
6. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res 1997; 80: 829-37.
7. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 2000; 102: 185-90.
8. Blann AD, Belgore FM, Constans J, Conri C, Lip GY. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol 2001; 87: 1160-3.